Target intelligence / Profile preview

DNAJA2 divergent transcript (DNAJA2-DT)

Target: DNAJA2-DT
Molecular classification: Other (likely a long non-coding RNA, if anything; not a receptor, enzyme, transporter, etc.)

Overview

DNAJA2 divergent transcript (DNAJA2-DT) is presumed to be a non-coding RNA arising from the region adjacent to the DNAJA2 gene. The DNAJA2 protein itself is a heat shock protein co-chaperone implicated in DNA repair and protein homeostasis, but DNAJA2-DT is not currently recognized as a receptor, enzyme, or other tractable therapeutic target. There is no clear evidence of biological function, disease association, or drug interaction for this transcript in the literature. If “DNAJA2-DT” refers to a novel or predicted non-coding transcript, its biological relevance has not yet been validated and should be interpreted with caution.

Other names: DNAJA2-DT

Beyond the preview

Go deeper on DNAJA2 divergent transcript (DNAJA2-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNAJA2 divergent transcript (DNAJA2-DT).

Explore the full profile